2005
DOI: 10.1002/mrm.20405
|View full text |Cite
|
Sign up to set email alerts
|

Shutter‐speed analysis of contrast reagent bolus‐tracking data: Preliminary observations in benign and malignant breast disease

Abstract: The standard pharmacokinetic model applied to contrast reagent (CR) bolus-tracking (B-T) MRI (dynamic-contrast-enhanced) data makes the intrinsic assumption that equilibrium transcytolemmal water molecule exchange is effectively infinitely fast. Theory and simulation have suggested that this assumption can lead to significant errors. Recent analyses of animal model experimental data have confirmed two predicted signature inadequacies: a specific temporal mismatch with the B-T time-course and a CR dose-dependen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
103
1

Year Published

2006
2006
2013
2013

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 64 publications
(116 citation statements)
references
References 21 publications
12
103
1
Order By: Relevance
“…These images were acquired with adipose -1 H 2 C-suppression (institutional protocol required). In contrast to those (13,14) obtained with no fat suppression, these darker images show glandular regions brighter than fatty tissues. (Fig.…”
Section: Resultscontrasting
confidence: 57%
See 3 more Smart Citations
“…These images were acquired with adipose -1 H 2 C-suppression (institutional protocol required). In contrast to those (13,14) obtained with no fat suppression, these darker images show glandular regions brighter than fatty tissues. (Fig.…”
Section: Resultscontrasting
confidence: 57%
“…We also used the FXR-and SXR-allowed (FXR-a and SXR-a) versions of the first-generation ShutterSpeed Model (SSM1), BOLus Enhanced Relaxation Overview (BOLERO) (8,11). In the SM analyses, the parameters varied are K trans and v e , while the i value is (implicitly) zero (11,13,14).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…This apparent discrepancy regarding the efficacy of PK parameters may be due to the relatively small number of cases included in various studies, or the wide variety of DCE-MRI acquisition and PK analysis techniques used. Intra-tumour vascular heterogeneity might also be significant in some breast cancers (Hayes et al, 2002), leading to the possible breakdown of PK model assumptions such as the fast exchange limit within better-perfused regions (usually located at the tumour rim) (Zhou et al, 2004;Li et al, 2005). This could present a complicating factor in obtaining reliable results, an issue not addressed in this study, which utilised a whole ROI approach so as to minimise the effects of intra-scan patient motion.…”
Section: Discussionmentioning
confidence: 98%